Organ-on-chip (OOC) market encompasses the sales of organs-on-chips by a variety of companies that manufacture the organs-on-chips, basically used for toxicity testing, drug development, and personalized medicine research. Organs-on-chips are very small plastic devices with biocompatible micro-fluidic chambers that contain numerous live human-cells in a three dimensional (3D) culture that replicate the key physiological functions of body organs. Organs-on-chips that imitate human physiology at the organ level are a promising alternative to animal models. The design & development of an OOC is made possible through the use of relevant new techniques from cell biology, microfluidics, microfabrication, material science and nanotechnology. The specific design of the chip varies depending on the manufacturing process and the simulated organ, although the basic structure is usually the same.
Some of the key end-users of organ-on-chip market include pharmaceutical companies, research organizations, and more. The pharmaceutical companies are touted as the largest segment of the market due to the increasing number of pharmaceutical companies using OOCs for drug-toxicity, efficacy testing, and research & development (R&D). Research-organization segment procures the second position in the regional market, given the increasing number of non-profit research centers, leading research organizations, and universities that are committed to pursuing OOCs in the advanced drug toxicology tests.
As per analysis, Asia Pacific Organ-on-Chip Market 2020-2030 by Offering (Chips, Service), Organ Type (Liver, Heart, Lung, Kidney, Brain, Skin), Material (Polymers, Glass, Silicon), Application, End User, and Country: Trend Forecast and Growth Opportunity. Some of the key companies operating in the Asia-Pacific OOC market include Tara Biosystems Inc., Organovo, Inc., Cherry Biotech, MIMETAS BV, CN Bio Innovations, Ltd., AxoSim Inc., InSphero AG, Hurel Corporation, Emulate Inc., BiomimX SRL, Kirkstall, Ltd., Nortis Inc., TissUse GmbH, SynVivo, Inc. and among others. Renowned players use acquisitions, collaborations, partnerships, expansions and product launches to gain a competitive advantage in the market and to assert their market position. These players compete on the pricing & services. Vendors working in the regional market strive to deliver the top quality products & services based on innovative technologies along with best practices. Players make a significant investment for R&D and to secure a definite resource for the customers.
The Asia-Pacific organ-on-chip market is primarily driven by growth in trends of organ-on-chip for drug screening due to its application in quick sample reviewing. In addition, organ-on-chip technology is utilized in in-vitro analysis of the biochemical and other forms of metabolic & genetic activities of body-cells in tissues. Moreover, the organizations concerned in the regional organ-on-chip industry are following effective steps & strategies for launching of novel products to grow in the market.
The Asia-Pacific region is touted as the fastest growth rate in the coming years as the region has a favorable regulatory framework that has increased the OOC approval rate in South Korea, Australia, China and Japan. In addition, the high exposure to various chronic diseases, the extensive use of OOC devices by the healthcare industry, and the increasing demand for drug screening will add market value in the upcoming years. In addition, the increasing demand for OOC from kidney & lung-based organ cultures and absurd increase in research activities on OOC devices could also have a positive impact on the regional market.
For More Information, click on the link below:-
Asia Pacific Organ-on-Chip Market Research Report
Related Report:-
Contact Us:-
Ken Research
Ankur Gupta, Head Marketing & Communications
+91-9015378249
